Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Jiarou Wang"'
Tanshinone IIA alleviates atherosclerosis in LDLR−/− mice by regulating efferocytosis of macrophages
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Tanshinone IIA (TIIA) is the major lipid-soluble active ingredient of the traditional Chinese medicine Salvia miltiorrhiza, which slows down atherosclerosis (AS). However, it remains unclear whether TIIA has the potential to enhance macro
Externí odkaz:
https://doaj.org/article/2dbba5f9472d4d07aa6d578d62aceaf7
Publikováno v:
Journal of Translational Medicine, Vol 20, Iss 1, Pp 1-17 (2022)
Abstract Background Peripheral biomarkers are increasingly vital non-invasive methods for monitoring coronary artery disease (CAD) progression. Their superiority in early detection, prognosis evaluation and classified diagnosis is becoming irreplacea
Externí odkaz:
https://doaj.org/article/cc0fbe7f188c4f04b124c53338c2e3e0
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Cancer represents one of the leading causes of mortality worldwide. Conventional clinical treatments include radiation therapy, chemotherapy, immunotherapy, and targeted therapy. However, these treatments have inherent limitations, such as multidrug
Externí odkaz:
https://doaj.org/article/168d7343b7e343aba395fb294726de49
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Tea has long been valued for its health benefits, especially its potential to prevent and treat atherosclerosis (AS). Abnormal lipid metabolism and oxidative stress are major factors that contribute to the development of AS. Tea, which originated in
Externí odkaz:
https://doaj.org/article/d4c1d5d2fafe40589c3ea146e128f40b
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 10 (2023)
BackgroundAtherosclerosis (AS) has long been recognized as a cardiovascular disease and stroke risk factor. A well-known traditional Chinese medicine prescription, Tao Hong decoction (THD), has been proven effective in treating AS, but its mechanism
Externí odkaz:
https://doaj.org/article/3a219d73e03f47a49464e184d3a6311e
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Astragaloside IV (AS-IV) is the main active compound of Astragalus membranaceus. In this study, we investigated whether AS-IV could attenuate atherosclerosis and hepatic steatosis in LDLR−/−mice and its potential mechanisms. After 12 weeks of hig
Externí odkaz:
https://doaj.org/article/aefacdc9c3774bd5ae34372248c98163
Publikováno v:
PLoS ONE, Vol 17, Iss 5, p e0267968 (2022)
BackgroundAtherosclerosis(AS) is widely recognized as a risk factor for incident cardiovascular and cerebrovascular diseases. Tetramethylpyrazine (TMP) is the active ingredient of Ligusticum wallichii that possesses a variety of biological activities
Externí odkaz:
https://doaj.org/article/bd5658529ab34703ba9b218ee8821244
Autor:
Guochang Wang, Linlin Li, Jiarou Wang, Jie Zang, Jingci Chen, Yu Xiao, Xinrong Fan, Lin Zhu, Hank F. Kung, Zhaohui Zhu
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 50:1499-1509
Autor:
Rongxi Wang, Vivianne Jakobsson, Jiarou Wang, Tianzhi Zhao, Xingtong Peng, Bowen Li, Jianchao Xue, Naixin Liang, Zhaohui Zhu, Xiaoyuan Chen, Jingjing Zhang
Publikováno v:
Theranostics. 13:2979-2992
Autor:
Jiarou Wang, Nanze Yu, Guochang Wang, Rongxi Wang, Linlin Li, Yuanyuan Jiang, Huimin Sui, Yixin Sun, Zhijin Li, Xiao Long, Zhaohui Zhu
Publikováno v:
Clinical Nuclear Medicine; Jan2024, Vol. 49 Issue 1, p16-22, 7p